CHARLES RIVER LABS INTL INC's gross profit margin for the fourth quarter of its fiscal year 2015 has increased when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. CHARLES RIVER LABS INTL INC has average liquidity. Currently, the Quick Ratio is 1.31 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.
During the same period, stockholders' equity ("net worth") has increased by 9.05% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY15||Q4 FY14|
|Net Sales ($mil)||353.85||329.55|
|Net Income ($mil)||31.88||27.17|
|Balance Sheet||Q4 FY15||Q4 FY14|
|Cash & Equiv. ($mil)||138.73||178.74|
|Total Assets ($mil)||2068.5||1885.19|
|Total Debt ($mil)||863.03||777.86|
|Profitability||Q4 FY15||Q4 FY14|
|Gross Profit Margin||44.48||41.84|
|Return on Assets||7.21||6.72|
|Return on Equity||20.49||19.1|
|Debt||Q4 FY15||Q4 FY14|
|Share Data||Q4 FY15||Q4 FY14|
|Shares outstanding (mil)||46.7||47.33|
|Div / share||0.0||0.0|
|Book value / share||15.7||14.2|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||528393.0||528908.0|
BUY. CHARLES RIVER LABS INTL INC's P/E ratio indicates a discount compared to an average of 31.46 for the Life Sciences Tools & Services industry and a value on par with the S&P 500 average of 23.99. For additional comparison, its price-to-book ratio of 5.10 indicates a significant premium versus the S&P 500 average of 2.74 and a discount versus the industry average of 5.24. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. Upon assessment of these and other key valuation criteria, CHARLES RIVER LABS INTL INC proves to trade at a discount to investment alternatives within the industry.
|CRL 25.33||Peers 31.46||CRL 13.05||Peers 21.22|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
CRL is trading at a discount to its peers.
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
CRL is trading at a significant discount to its peers.
|CRL 16.01||Peers 23.33||CRL 0.67||Peers 1.18|
Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.
CRL is trading at a discount to its peers.
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
CRL trades at a significant discount to its peers.
|CRL 5.10||Peers 5.24||CRL 17.47||Peers 43.57|
Average. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CRL is trading at a valuation on par with its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, CRL is expected to significantly trail its peers on the basis of its earnings growth rate.
|CRL 2.74||Peers 20.31||CRL 5.05||Peers 8.34|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CRL is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
CRL significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.